Absci prepares for next stage of growth with executive human resources and marketing hires

Vancouver, wash. and new york, july 14, 2022 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today announced two senior executive hires in newly created roles as it prepares for its next stage of growth.
ABSI Ratings Summary
ABSI Quant Ranking